Human FABP-3 L-ELISA quantifies the Human FABP-3 in human serum, plasma or cell culture medium. The dosage will only recognize natural and recombinant Hu FABP-3.
Human FABP-3 L-ELISA quantifies the Human FABP-3 in human serum, plasma or cell culture medium. The dosage will only recognize natural and recombinant Hu FABP-3.
Method principle
L-ELISA Human FABP-3 solid phase sandwich (dose d-immunoabsorption by bound enzyme) is designed to measure the amount of the target bound between a pair of matched antibodies. A target-specific antibody was pre-vested in the wells of the supplied microplate. Samples, standards or controls are then added to these wells and bound to immobilized antibody (capture). The sandwich is formed by adding the second antibody (detector), binding to the target on a different epitope from the capture antibody. A conjugate enzyme was incorporated into the assay. After incubation and washing steps to remove the microplate from the non-bonded substances, a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this coloured product is directly proportional to the concentration of TP (p) present in the original sample.
Strict validation
Each batch manufactured from this ELISA kit is tested according to its quality for criteria such as sensitivity, specificity, accuracy and batch-to-batch consistency. See the product manual for more information on validation.
Intracellular fatty acid binding proteins belong to a multigenic family. FABPs are divided into at least three distinct types, namely, liver, intestinal and cardiac. They form proteins of 14-15 kDa and are thought to be involved in absorption, intracellular metabolism and/or transport of long-chain fatty acids. They may also be responsible for modulation of cell growth and proliferation. The heart-type fatty acid binding protein gene 3 contains four exons and its function is to stop the growth of breast epithelial cells. This gene is a candidate tumor suppressor gene for human breast cancer.
Sensitivity
Sensitivity of the dosage: 26.88 pg/ml.
Measurement range
Dose range: 156.3-5000 pg/ml.
Duration of dosing
Total duration of dosing: 4 hours.
Reproducibility
Coefficient of variation between doses 3.9%, interdose 6.2%.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15974204 |
| Specifications |
| Accession number | P05413 |
| Dose range | 156.3-5000 pg/ml |
| Sensitivity of the dosage | 26.88 pg/ml |
| Conjugate | Biotin |
| Product type | Kit ELISA |
| Type of sample | Cellular lysates, Serum, Surnatant, Surnatant |
| Target species | Human |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 2170 |
| Gene symbol(s) | FABP3 |
| Coefficient of inter-dose variation | 6.2% |
| Coefficient of intra-dose variation | 3.9% |
| Contents of kits | 96-well pre-coated plate, Standard (2 vials), Standard dilution stamp, Biotinylated detection anticorps, Streptavidine HRP, HRP diluent, Wash pad, Chromagen, Stop solution, Adhesive plate covers |
| Marker or dye | HRP |
| Quantity | 96 tests |
| Regulatory status | RUO |
| Target | Human |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Serum, 50 μl; plasma, 50 μl; cell lysate, 50 μl; supernatant, 50 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4 h |
Origin and customs
| Manufacturer ref. | BMS2263 |
|---|
| Country of origin | Autriche |
|---|
| HS customs code | 3002 15 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.